Searched for
DRUG PRICING IN AMERICA
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...- US stocks today: US stocks climb as US, Iran halt attacks; Comcast surges on spin-off planWall Street's indices surged on Monday, lifted by a decrease in Middle East tensions and Comcast’s intention to divide into two separate fi...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Pizza Hut: From $600 loan to 20,000 stores and the new $2.7 billion twist for the global empirePizza Hut, a nearly 70-year-old American icon, has been split in a $2.7 billion deal. Yum Brands is selling its international business outs...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- From white knuckles to open barbs, Trump, Macron bring rocky history to G7 summitThe bond between US President Donald Trump and French President Emmanuel Macron began with a firm handshake but has since seen open disagre...
- Trump has a new, surprising take on the higher cost of living: 'I love the inflation'President Trump surprised many by stating he loves inflation. He linked rising prices to the Iran war. Trump also claimed secret military a...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Despite Trump's pressure, Cuba may not turn out like VenezuelaThe U.S. is increasing pressure on Cuba, but unlike Venezuela, the island nation lacks a clear opposition leader or succession plan. Cuba's...
- The Iran war is now changing your Social Security check; here's the new 2027 COLA numberSocial Security COLA update 2027: Gas prices in America have surged above $4.10 per gallon, up sharply from $3.17 last year, and the impact...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Pharma exports surpass $31 billion in FY26 despite global headwindsIndian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...
- India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
Load More
